Blood cancer patients on Bruton's tyrosine kinase inhibitors should continue at time of COVID-19 vaccination, study says
Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...
COVID-19 boosters help avoid breakthrough infections in immunocompromised people, study finds
New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain ...
Physician's Weekly13d
Repeated N-Antigen Antibody Monitoring for Assessing SARS-CoV-2 Exposure
CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 ...
Just The News4d
Repeat COVID vaccines provoke two kinds of inferior antibodies, study finds
Not just IgG4 antibodies that become predominant in the many-jabbed, but also lesser studied IgG2, researchers find. NIH ...
University of Birmingham1d
Some cancer patients can safely continue treatment and receive COVID-19 vaccination, study shows
Evidence shows pausing BTKi therapy for COVID-19 vaccination does not affect antibody responses to the vaccine ...
Medical Dialogues1d
Newer hepatitis B vaccine shows promise as booster for health care workers: Study
Health care workers are at higher risk of hepatitis B infection due to occupational exposure to blood and body fluids. They ...
Prometheus Laboratories Launches New Anser(R) Test for Risankizumab
New Therapeutic Drug Monitoring Test for Interleukin‐23 Inhibitor SAN DIEGO, CA / ACCESS Newswire / April 1, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision-guided medicine, ...